{"name":"Thomas, McNerney & Partners","permalink":"thomas-mcnerney-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/thomas-mcnerney-partners","homepage_url":"http://www.tm-partners.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"203-978-2000","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"health-care-venture-capital-firm-pharmaceutical-medical-device-biotechnology-diagnostic-sectors-medical-technology-innovation","alias_list":"","created_at":"Thu Nov 12 00:20:02 UTC 2009","updated_at":"Thu Mar 25 12:35:36 UTC 2010","overview":"<p>Thomas, McNerney &amp; Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies. </p>\n\n<p>The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest.</p>\n\n<p>Thomas, McNerney &amp; Partners invests in companies at all stages of their development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. The partnership also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations.</p>","image":{"available_sizes":[[[150,18],"assets/images/resized/0008/1733/81733v1-max-150x150.png"],[[250,30],"assets/images/resized/0008/1733/81733v1-max-250x250.png"],[[450,54],"assets/images/resized/0008/1733/81733v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"One Stamford Plaza 263 Tresser Blvd Suite 1600","address2":"","zip_code":"06901","city":"Stamford","state_code":"CT","country_code":"USA","latitude":null,"longitude":null},{"description":"","address1":"60 South 6th Street Suite 3620","address2":"","zip_code":"55402","city":"Minneapolis","state_code":"MN","country_code":"USA","latitude":null,"longitude":null},{"description":"","address1":"150 Spear Street Suite 1050","address2":"","zip_code":"94105","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Vice President","person":{"first_name":"ANYA","last_name":"SCHIESS","permalink":"anya-schiess","image":{"available_sizes":[[[97,150],"assets/images/resized/0011/9072/119072v1-max-150x150.jpg"],[[140,215],"assets/images/resized/0011/9072/119072v1-max-250x250.jpg"],[[140,215],"assets/images/resized/0011/9072/119072v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Alex","last_name":"Zisson","permalink":"alex-zisson","image":null}},{"is_past":false,"title":"Partner","person":{"first_name":"Peter","last_name":"H. McNerney","permalink":"peter-h-mcnerney","image":null}},{"is_past":false,"title":"Partner","person":{"first_name":"James","last_name":"E. Thomas","permalink":"james-e-thomas","image":null}},{"is_past":false,"title":"Partner","person":{"first_name":"KATHLEEN","last_name":"A. TUNE","permalink":"kathleen-a-tune","image":{"available_sizes":[[[97,150],"assets/images/resized/0011/9071/119071v1-max-150x150.jpg"],[[140,215],"assets/images/resized/0011/9071/119071v1-max-250x250.jpg"],[[140,215],"assets/images/resized/0011/9071/119071v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/altair-therapeutics-inc-series-b-17m/","source_description":"Altair Therapeutics, Inc.: Series B $17M","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":2,"company":{"name":"Altair Therapeutics","permalink":"altair-therapeutics","image":{"available_sizes":[[[150,63],"assets/images/resized/0006/5844/65844v1-max-150x150.png"],[[238,100],"assets/images/resized/0006/5844/65844v1-max-250x250.png"],[[238,100],"assets/images/resized/0006/5844/65844v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/virdante-pharmaceuticals-inc-series-a-30m/","source_description":"Virdante Pharmaceuticals, Inc.: Series A $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":25,"company":{"name":"Virdante Pharmaceuticals","permalink":"virdante-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0006/4176/64176v1-max-150x150.jpg"],[[250,71],"assets/images/resized/0006/4176/64176v1-max-250x250.jpg"],[[278,79],"assets/images/resized/0006/4176/64176v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/quinnova-pharmaceuticals-inc-series-b-174m/","source_description":"Quinnova Pharmaceuticals, Inc.: Series B $17.4M","raised_amount":17400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":25,"company":{"name":"Quinnova Pharmaceuticals","permalink":"quinnova-pharmaceuticals","image":{"available_sizes":[[[150,51],"assets/images/resized/0006/7684/67684v1-max-150x150.png"],[[220,76],"assets/images/resized/0006/7684/67684v1-max-250x250.png"],[[220,76],"assets/images/resized/0006/7684/67684v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2010/01/intuity-medical-secures-64m-in-series-d.html","source_description":"Intuity Medical Secures $64M in Series D Financing Round","raised_amount":64000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":5,"company":{"name":"Intuity Medical","permalink":"intuity-medical","image":{"available_sizes":[[[148,46],"assets/images/resized/0007/2280/72280v1-max-150x150.jpg"],[[148,46],"assets/images/resized/0007/2280/72280v1-max-250x250.jpg"],[[148,46],"assets/images/resized/0007/2280/72280v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.solsticeneuro.com/news/Highland_Capital_PR11-08-06.html","source_description":"Solstice Neurosciences Raises $85 Million in Private Financing","raised_amount":85000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":8,"company":{"name":"Solstice Neurosciences","permalink":"solstice-neurosciences","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/4219/84219v1-max-150x150.jpg"],[[162,61],"assets/images/resized/0008/4219/84219v1-max-250x250.jpg"],[[162,61],"assets/images/resized/0008/4219/84219v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.zogenix.com/index.php/news/zogenix-inc-raises-60-million-in-series-a-venture-financing-names-board-of-directors/","source_description":"Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":28,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/big-pharma-groups-back-43m-round-neurotherapeutics/2010-05-20?utm_medium=rss&utm_source=rss","source_description":"Big Pharma firms back $43M round for NeuroTherapeutics","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":20,"company":{"name":"NeuroTherapeutics Pharma","permalink":"neurotherapeutics-pharma","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/8127/88127v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0008/8127/88127v1-max-250x250.jpg"],[[318,97],"assets/images/resized/0008/8127/88127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":7,"funded_day":1,"company":{"name":"Solstice Neurosciences","permalink":"solstice-neurosciences","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/4219/84219v1-max-150x150.jpg"],[[162,61],"assets/images/resized/0008/4219/84219v1-max-250x250.jpg"],[[162,61],"assets/images/resized/0008/4219/84219v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.galil-medical.com/press-releases/press-release-11-12-06.html","source_description":"company press release","raised_amount":52000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":11,"company":{"name":"Galil Medical","permalink":"galil-medical","image":{"available_sizes":[[[150,35],"assets/images/resized/0009/6226/96226v2-max-150x150.jpg"],[[250,58],"assets/images/resized/0009/6226/96226v2-max-250x250.jpg"],[[388,91],"assets/images/resized/0009/6226/96226v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.celatorpharma.com/new/pr_20100901.html","source_description":"CELATORÂ® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"company":{"name":"Celator Pharmaceuticals","permalink":"celator-pharmaceuticals","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/0352/100352v1-max-150x150.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-250x250.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/san-diego/2010/09/01/cebix-raises-16m-from-investors/","source_description":"Cebix Raises $16M From Investors","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"company":{"name":"Cebix","permalink":"cebix","image":{"available_sizes":[[[150,82],"assets/images/resized/0010/0917/100917v1-max-150x150.png"],[[162,89],"assets/images/resized/0010/0917/100917v1-max-250x250.png"],[[162,89],"assets/images/resized/0010/0917/100917v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/auspex-pharmaceuticals-inc-12m-series-c/","source_description":"Auspex Pharmaceuticals, Inc.: $12M Series C","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":13,"company":{"name":"Auspex Pharmaceuticals","permalink":"auspex-pharmaceuticals","image":{"available_sizes":[[[150,68],"assets/images/resized/0010/6209/106209v1-max-150x150.png"],[[158,72],"assets/images/resized/0010/6209/106209v1-max-250x250.png"],[[158,72],"assets/images/resized/0010/6209/106209v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/onbiovc-post-1000-axiomed-spine-corp-series-d-15m/","source_description":"**OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":25,"company":{"name":"AxioMed Spine","permalink":"axiomed-spine","image":{"available_sizes":[[[150,43],"assets/images/resized/0010/7451/107451v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0010/7451/107451v1-max-250x250.jpg"],[[326,95],"assets/images/resized/0010/7451/107451v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-secures-35-million-debt-facility-and-raises-15-million-investment-capital/","source_description":"Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":13,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.devicespace.com/news_story.aspx?NewsEntityId=223557&Source=YesterdaysMostPopular","source_description":"CAS Medical Systems Raises $15 Million in Private Placement","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":9,"company":{"name":"CAS Medical Systems","permalink":"cas-medical-systems","image":{"available_sizes":[[[150,59],"assets/images/resized/0013/9030/139030v1-max-150x150.jpg"],[[213,84],"assets/images/resized/0013/9030/139030v1-max-250x250.jpg"],[[213,84],"assets/images/resized/0013/9030/139030v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/12/innopharma-closes-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"InnoPharma Closes $15M Series A Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":2,"company":{"name":"InnoPharma","permalink":"innopharma","image":{"available_sizes":[[[150,43],"assets/images/resized/0016/5000/165000v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0016/5000/165000v1-max-250x250.jpg"],[[302,87],"assets/images/resized/0016/5000/165000v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.businessreel.com/news/view/sg-biofuels-raises-17m-from-thomas-mcnerney-finistere-others/","source_description":"SG Biofuels Raises $17M From Thomas McNerney, Finistere, Others","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":17,"company":{"name":"SG Biofuels","permalink":"sg-biofuels","image":{"available_sizes":[[[150,60],"assets/images/resized/0010/1756/101756v1-max-150x150.png"],[[187,76],"assets/images/resized/0010/1756/101756v1-max-250x250.png"],[[187,76],"assets/images/resized/0010/1756/101756v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.tiogapharma.com/press/Tioga%20Series%20B%20PR%20FINAL.pdf","source_description":"Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":12,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/09/torax-medical-completes-30m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Torax Medical Completes $30M Series D Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":19,"company":{"name":"Torax Medical","permalink":"torax-medical","image":{"available_sizes":[[[150,47],"assets/images/resized/0021/2367/212367v1-max-150x150.png"],[[250,78],"assets/images/resized/0021/2367/212367v1-max-250x250.png"],[[337,106],"assets/images/resized/0021/2367/212367v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.pehub.com/170011/cebix-incorporated-inks-30-9m-series-c-appoints-president-ceo/","source_description":"Cebix Incorporated Inks $30.9m Series C and Appoints President and CEO","raised_amount":30900000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":18,"company":{"name":"Cebix","permalink":"cebix","image":{"available_sizes":[[[150,82],"assets/images/resized/0010/0917/100917v1-max-150x150.png"],[[162,89],"assets/images/resized/0010/0917/100917v1-max-250x250.png"],[[162,89],"assets/images/resized/0010/0917/100917v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}